Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., et al. (2001) Lack of Hepcidin Gene Expression and Severe Tissue Iron Overload in Upstream Stimulatory Factor 2 (USF2) Knockout Mice. Proceedings of the National Academy of Sciences of the United States of America, 98, 8780-8785.
https://doi.org/10.1073/pnas.151179498

has been cited by the following article:

• TITLE: A Novel Approach for Iron Deficiency Anaemia with Liposomal Iron: Concept to Clinic

  AUTHORS: Manish Maladkar, Srividya Sankar, Ashok Yadav

  KEYWORDS: Liposomal Iron, Iron Deficiency, Anaemia, Microencapsulation, Micronisation, Pregnancy, Inflammation, Chronic Kidney Disease

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.8 No.9, September 9, 2020

  ABSTRACT: Iron deficiency anaemia is the most common nutritional deficiency disorder, contributing to 50 percent of all the anaemias in the world. Dietary changes alone are insufficient for the correction and management of iron deficiency anaemia. Hence, iron supplementation is necessary. Conventional oral iron therapy is limited in many patients because of dose dependent side effects, insufficient absorption, lack of compliance and limitation in various inflammatory conditions. Liposomal iron is a technologically designed, innovative form of iron which due to its differential delivery system ensures higher absorption and bioavailability, greater tolerability and least gastro-intestinal side effects unlike conventional oral iron preparations. This review provides a critical discussion and a comprehensive view based on the author’s review of the medical literature concerning the technology of liposomal iron preparation, mechanism of its absorption, its advantage over conventional iron preparations and clinical evidence on its usage in iron deficient states in pregnancy and certain inflammatory conditions.